1 authorised product containing Inebilizumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Uplizna 100 mg concentrate for solution for infusion EU/1/21/1602/001 |
Inebilizumab | Amgen Europe B.V., | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.